January 5, 2010 -- San
Diego -- Volcano Corporation (Nasdaq:
VOLC) a leader in the development, manufacture and sales of
products for the diagnosis and treatment of coronary and peripheral
artery disease, said today that it will be participating in
the 28th Annual J.P. Morgan Healthcare Conference on Tuesday,
January 12.
The presentation by Scott Huennekens, president
and chief executive officer, will begin at 2 p.m., Pacific
Standard Time, (5 p.m., Eastern Standard Time). |